英文原著

2016

Okuma K, Yamashita H, Yokoyama T, Nakagawa K, Kawana K. Undetected human papillomavirus DNA and uterine cervical carcinoma: Association with cancer recurrence. Strahlenther Oncol.192(1), 55-62, 2016.

Yamashita H, Haga A, Takenaka R, Kiritoshi T, Okuma K, Ohtomo K, Nakagawa K. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer. Radiat Oncol. 19, 11:4, 2016.

Sakumi A, Miyagawa R, Tamari Y, Nawa K, Sakura O, Nakagawa K. External effective radiation dose to workers in the restricted area of the Fukushima Daiichi Nuclear Power Plant during the third year after the Great East Japan Earthquake. J Radiat Res. 57(2), 178-81, 2016.

Kobayashi R, Yamashita H, Okuma K, Ohtomo K, Nakagawa K. Details of recurrence sites after definitive radiation therapy for cervical cancer. J Gynecol Oncol. 27(2), e16, 2016.

Shibata S, Shiraishi K, Yamashita H, Kobayashi R, Nakagawa K. Radiation-induced low-grade fibromyxoid sarcoma of the chest wall nine years subsequent to radiotherapy for breast carcinoma: A case report. Oncol Lett.11(4), 2520-2524, 2016.

Karube M, Yamamoto N, Nakajima M, Yamashita H, Nakagawa K, Miyamoto T, Tsuji H, Fujisawa T, Kamada T. Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older with Stage I Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 1;95(1), 542-8, 2016.

Katano A, Yamashita H, Okuma K, Nakagawa K. Complete response to abdominal bulky lymph node recurrence in an esophageal cancer patient treated with S-1 monotherapy: A case report. Oncol Lett.11(6), 3901-3903, 2016.

Yamashita H, Niibe Y, Yamamoto T, Katsui K, Jingu K, Kanazawa S, Terahara A, Nakagawa K. Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases. Jpn J Clin Oncol. 46(7), 687-91, 2016.

Tamari Y, Kuroda Y, Miyagawa R, Nawa K, Sakumi A, Sakata N, Mizushima N, Sakura O, Iwamitsu Y, Takemura K, Nakagawa K. A report that Fukushima residents are concerned about radiation from Land, Food and Radon. J Radiat Res. 57(4), 418-21, 2016.

Yamashita H, Takenaka R, Okuma K, Ootomo K, Nakagawa K. Prognostic factors in patients after definitive chemoradiation using involved-field radiotherapy for esophageal cancer in a phase II study. Thorac Cancer. 7(5), 564-569, 2016.

Taguchi S, Shiraishi K, Fukuhara H, Nakagawa K, Morikawa T, Naito A, Kakutani S, Takeshima Y, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Homma Y. Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial? Radiat Oncol. 30, 11:102, 2016.

Karube M, Mori S, Tsuji H, Yamamoto N, Nakajima M, Nakagawa K, Kamada T. Carbon-ion pencil beam scanning for thoracic treatment – initiation report and dose metrics evaluation. J Radiat Res.57(5), 576-581, 2016.

Taguchi S, Shiraishi K, Fukuhara H, Nakagawa K, Morikawa T, Naito A, Kakutani S, Takeshima Y, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Homma Y. Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer. Int J Clin Oncol.21(5), 975-980, 2016.

Okuma K, Shiraishi K, Kanai Y, Nakagawa K. Improvement in quality of life by using duloxetine for chemotherapy-induced peripheral neuropathy (CIPN): a case report. Support Care Cancer. 24(11), 4483-5, 2016.

Kobayashi R, Miyagawa R, Yamashita H, Morikawa T, Okuma K, Fukayama M, Ohtomo K, Nakagawa K. Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy. Oncol Lett.12(5), 3066-3074, 2016.

Takenaka R, Yamashita H, Toya T, Haga A, Shibata S, Kurokawa M, Ootomo K, Nakagawa K. Unique radiation dermatitis related to total body irradiation by helical tomotherapy. J Dermatol. 43(11), 1376-1377, 2016.

Magome T, Froelich J, Takahashi Y, Arentsen L, Holtan S, Verneris MR, Brown K, Haga A, Nakagawa K, Holter Chakrabarty JL, Giebel S, Wong J, Dusenbery K, Storme G, Hui SK. Evaluation of Functional Marrow Irradiation Based on Skeletal Marrow Composition Obtained Using Dual-Energy Computed Tomography. Int J Radiat Oncol Biol Phys. 1;96(3), 679-87, 2016.

Magome T, Haga A, Takahashi Y, Nakagawa K, Dusenbery KE, Hui SK. Fast Megavoltage Computed Tomography: A Rapid Imaging Method for Total Body or Marrow Irradiation in Helical Tomotherapy. Int J Radiat Oncol Biol Phys. 1;96(3), 688-95, 2016.

英文原著

2015

Kobayashi R, Shiraishi K, Iwase S, Ohtomo K, Nakagawa K. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients. Breast Cancer. 22(6), 657-63, 2015.

Kuroda Y, Iwamitsu Y, Miyashita M, Hirai K, Kanai Y, Kawakami S, Nakano K, Nakagawa K. Views on death with regard to end-of-life care preferences among cancer patients at a Japanese university hospital. Palliat Support Care. 13(4), 969-79, 2015.

Ito T, Hanafusa N, Iwase S, Noiri E, Nangaku M, Nakagawa K, Miyagawa K. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites. Int J Clin Oncol.20(3), 623-8, 2015.

Miyashita M, Kawakami S, Kato D, Yamashita H, Igaki H, Nakano K, Kuroda Y, Nakagawa K. The importance of good death components among cancer patients, the general population, oncologists, and oncology nurses in Japan: patients prefer “fighting against cancer”. Support Care Cancer.23(1), 103-10, 2015.
Yamashita H, Takenaka R, Sakumi A, Haga A, Otomo K, Nakagawa K. Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography. Radiat Oncol.8, 10, 2, 2015.

Takahashi W, Nakajima M, Yamamoto N, Yamashita H, Nakagawa K, Miyamoto T, Tsuji H, Kamada T, Fujisawa T. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC). Cancer. 2015.

Yamashita H, Onishi H, Murakami N, Matsumoto Y, Matsuo Y, Nomiya T, Nakagawa K; Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG). Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma. J Radiat Res.56(3), 561-7, 2015.

Yamashita M, Yamashita H, Shibata S, Okuma K, Nakagawa K. Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagia. Oncol Lett. 9(4), 1747-1752, 2015.

Okuma K, Yamashita H, Kobayashi R, Nakagawa K. A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer. J Contemp Brachytherapy. 7(2), 128-34, 2015.

Katano A, Takenaka R, Okuma K, Yamashita H, Nakagawa K. Repeated episodes of spontaneous regression/progression of cervical adenocarcinoma after adjuvant chemoradiation therapy: a case report. J Med Case Rep. 19, 9:114, 2015.

Aoyama H, Tago M, Shirato H; Japanese Radiation Oncology Study Group 99-1 (JROSG 99-1) Investigators. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial. JAMA Oncol. 1(4), 457-64, 2015.

Yamashita H, Takenaka R, Omori M, Imae T, Okuma K, Ohtomo K, Nakagawa K. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study. Radiat Oncol. 14, 10:171, 2015.
Niibe Y, Yamashita H, Sekiguchi K, Takahashi W, Shiraishi K, Okuma K, Terahara A, Kawamori J, Nakagawa K. Stereotactic Body Radiotherapy Results for Pulmonary Oligometastases: A Two-Institution Collaborative Investigation. Anticancer Res.35(9), 4903-8, 2015.

Taguchi S, Fukuhara H, Shiraishi K, Nakagawa K, Morikawa T, Kakutani S, Takeshima Y, Miyazaki H, Fujimura T, Nakagawa T, Kume H, Homma Y. Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality. PLoS One. 27;10(10), e0141123, 2015.

Kobayashi R, Shiraishi K, Iwase S, Ohtomo K, Nakagawa K. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients. Breast Cancer. 22(6), 657-63, 2015.

Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa K, Hareyama M, Takai Y, Hayakawa K, Mitsuhashi N, Ishikura S. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys. 1;93(5), 989-96, 2015.

英文原著

2014

Yamashita, H., Omori, M., Okuma, K., Kobayashi, R., Igaki, H., and Nakagawa, K. Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancer. Jpn J Clin Oncol. 44(1), 78-84, 2014.

Yamashita, H., Onishi, H., Matsumoto, Y., Murakami, N., Matsuo, Y., Nomiya, T., Nakagawa, K. and Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG). Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients. Radiat Oncol. 9(1), 112, 2014. doi: 10.1186/1748-717X-9-112.

Kobayashi, R., Shiraishi, K., Iwase, S., Ohtomo, K. and Nakagawa, K. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients. Breast Cancer. 2014 Apr 23. [Epub ahead of print] PubMed PMID:24756246.

Yamashita, H., Yamashita, M., Futaguchi, M., Takenaka, R., Shibata, S., Yamamoto, K., Nomoto, A., Sakumi, A., Kida, S., Kaneko, Y., Takenaka, S., Shiraki, T. and Nakagawa, K. Individually wide range of renal motion evaluated by four-dimensional computed tomography. Springerplus. 3, 131, 2014. doi: 10.1186/2193-1801-3-131.

Haga, A., Magome, T., Takenaka, S., Imae, T., Sakumi, A., Nomoto, A., Igaki, H., Shiraishi, K., Yamashita, H., Ohtomo, K. and Nakagawa, K. Independent absorbed-dose calculation using the Monte Carlo algorithm in volumetric modulated arc therapy. Radiat Oncol. 9, 75, 2014. doi: 10.1186/1748-717X-9-75.

Takahashi, W., Nakajima, M., Yamamoto, N., Yamada, S., Yamashita, H., Nakagawa, K., Tsuji, H. and Kamada, T. Carbon ion radiotherapy for oligo-recurrent lung metastases from colorectal cancer: a feasibility study. Radiat Oncol. 9, 68, 2014. doi:10.1186/1748-717X-9-68.

Yamashita, H., Okuma, K., Nomoto, A., Yamashita, M., Igaki, H. and Nakagawa, K. Extended cancer-free survival after palliative chemoradiation for metastatic esophageal cancer. World J Gastrointest Oncol. 6(2), 52-54, 2014.

Yamashita, H., Omori, M., Okuma, K., Kobayashi, R., Igaki, H. and Nakagawa, K. Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancer. Jpn J Clin Oncol. 44(1), 78-84, 2014.

Nakagawa, K., Haga, A., Sakumi, A., Yamashita, H., Igaki, H., Shiraki, T., Ohtomo, K., Iwai, Y. and Yoda, K. Impact of flattening-filter-free techniques on delivery time for lung stereotactic volumetric modulated arc therapy and image quality of concurrent kilovoltage cone-beam computed tomography: a preliminary phantom study. J Radiat Res. 55(1), 200-202, 2014.

Imae, T., Haga, A., Saotome, N., Kida, S., Nakano, M., Takenaka, S., Takeuchi, Y., Shiraki, T., Yano, K., Yamashita, H., Nakagawa, K. and Ohtomo, K. Dose Reconstruction Using Respiratory Signals and Machine Parameters during Treatment in Stereotactic Body Radiotherapy. Nihon Hoshasen Gijutsu Gakkai Zasshi. 70(11), 1225-1234, 2014.

Yamashita, H., Haga, A., Takahashi, W., Takenaka, R., Imae, T., Takenaka, S. and Nakagawa, K. Volumetric modulated arc therapy for lung stereotactic radiation therapy can achieve high local control rates. Radiat Oncol. 9(1), 243, 2014.

Takahashi, W., Mori, S., Nakajima, M., Yamamoto, N., Inaniwa, T., Furukawa, T., Shirai, T., Noda, K., Nakagawa, K. and Kamada, T. Carbon-ion scanning lung treatment planning with respiratory-gated phase-controlled rescanning: simulation study using 4-dimensional CT data. Radiat Oncol. 9(1), 238, 2014.

Yamashita, H., Takahashi, W., Haga, A. and Nakagawa, K. Radiation pneumonitis after stereotactic radiation therapy for lung cancer. World J Radiol. 6(9), 708-715, 2014.

Ito, T., Hanafusa, N., Iwase, S., Noiri, E., Nangaku, M., Nakagawa, K. and Miyagawa, K. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites. Int J Clin Oncol. 2014 Sep 20. [Epub ahead of print] PMID: 25239690

Igaki, H., Sakumi, A., Mukasa, A., Saito, K., Kunimatsu, A., Masutani, Y., Hanakita, S., Ino, K., Haga, A., Nakagawa, K. and Ohtomo, K. Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning. Rep Pract Oncol Radiother. 19(5), 310-316, 2014.

Yamashita, H., Takahashi, W., Haga, A., Kida, S., Saotome, N. and Nakagawa, K. Stereotactic body radiotherapy for small lung tumors in the University of Tokyo Hospital. Biomed Res Int. 2014;2014:136513. doi: 10.1155/2014/136513. Epub 2014 Jul 7. PMID: 25110653

Kanegasaki, S., Matsushima, K., Shiraishi, K., Nakagawa, K. and Tsuchiya, T. Macrophage inflammatory protein derivative ECI301 enhances the alarmin-associated abscopal benefits of tumor radiotherapy. Cancer Res. 74(18), 5070-5078, 2014. doi: 10.1158/0008-5472.CAN-14-0551.

Kuroda, Y., Iwamitsu, Y., Miyashita, M., Hirai, K., Kanai, Y., Kawakami, S., Nakano, K. and Nakagawa, K. Views on death with regard to end-of-life care preferences among cancer patients at a Japanese university hospital. Palliat Support Care. 2014 Jul 11:1-11. [Epub ahead of print] PMID: 25014469 [PubMed – as supplied by publisher]

Miyashita, M., Kawakami, S., Kato, D., Yamashita, H., Igaki, H., Nakano, K., Kuroda, Y. and Nakagawa, K. The importance of good death components among cancer patients, the general population, oncologists, and oncology nurses in Japan: patients prefer “fighting against cancer” Support Care Cancer. 2014 Jul 5. [Epub ahead of print] PMID: 24996829 [PubMed – as supplied by publisher]

Shiraishi, K., Futaguchi, M., Haga, A., Sakumi, A., Sasaki, K., Yamamoto, K., Igaki, H., Ohtomo, K., Yoda, K. and Nakagawa, K. Validation of planning target volume margins by analyzing intrafractional localization errors for 14 prostate cancer patients based on three-dimensional cross-correlation between the prostate images of planning CT and intrafraction cone-beam CT during volumetric modulated arc therapy. Biomed Res Int. 2014;2014:960928. doi: 10.1155/2014/960928. Epub 2014 May 22. PMID: 24977167 [PubMed – in process]

Nakagawa, K., Haga, A., Sasaki, K., Kida, S., Masutani, Y., Yamashita, H., Takahashi, W., Igaki, H., Sakumi, A., Ohtomo, K. and Yoda, K. Lung tumor motion reproducibility for five patients who received four-fraction VMAT stereotactic ablative body radiotherapy under constrained breathing conditions: a preliminary study. J Radiat Res. 55(6), 1199-1201, 2014.

Yamashita H, Omori M, Takenaka R, Okuma K, Kobayashi R, Ohtomo K, Nakagawa K. Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study. Radiother Oncol. 2014 Nov;113(2):182-7. doi: 10.1016/j.radonc.2014.11.004. Epub 2014 Nov 23. PubMed PMID: 25466372.

Yamashita M, Takenaka HY, Nakagawa K. Semi-radical chemoradiotherapy for 53 esophageal squamous cell carcinomas with supraclavicular lymph node metastasis in a single institutional retrospective study. Hepatogastroenterology. 2014 Oct;61(135):1971-8. PubMed PMID: 25713897.

Yamashita H, Takenaka R, Sakumi A, Haga A, Otomo K, Nakagawa K. Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography. Radiat Oncol. 2015 Jan 8;10(1):2. [Epub ahead of print] PubMed PMID: 25566869; PubMed Central PMCID: PMC4312441.

Takahashi W, Nakajima M, Yamamoto N, Yamashita H, Nakagawa K, Miyamoto T, Tsuji H, Kamada T, Fujisawa T. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC). Cancer. 2015 Jan 13. doi: 10.1002/cncr.29195. [Epub ahead of print] PubMed PMID: 25641119.

Yamashita H, Onishi H, Murakami N, Matsumoto Y, Matsuo Y, Nomiya T, Nakagawa K; Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG). Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma. J Radiat Res. 2015 Feb 16. pii: rru130. [Epub ahead of print] PubMed PMID: 25691453.

Yamashita M, Yamashita H, Shibata S, Okuma K, Nakagawa K. Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagia. Oncol Lett. 2015 Apr;9

NAGATA, Yasushi, et al. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys, 2015; 93.5: 989-996.

英文原著

2013

Hama, Y. and Nakagawa, K. Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases. Breast Cancer. 20(2), 2013.

Fukui, M., Iwase, S., Sakata, N., Kuroda, Y., Yoshiuchi, K., Nakagawa, K., Quinn, K. and Hudson, P. L. Effectiveness of using clinical guidelines for conducting palliative care family meetings in Japan. Support Care Cancer. 21(1), 53-58, 2013.

Matsuo, Y., Onishi, H., Nakagawa, K., Nakamura, M., Ariji, T., Kumazaki, Y., Shimbo, M., Tohyama, N., Nishio, T., Okumura, M., Shirato, H. and Hiraoka, M. Guidelines for respiratory motion management in radiation therapy. J Radiat Res. 54(3), 561-568, 2013.

Shibata-Kobayashi, S., Yamashita, H., Okuma, K., Shiraishi, K., Igaki, H., Ohtomo, K. and Nakagawa, K. Correlation among 16 biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A), cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2, EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma. Oncol Lett. 5(3), 903-910, 2013.

Onoe, T., Nose, T., Yamashita, H., Yoshioka, M., Toshiyasu, T., Kozuka, T., Oguchi, M. and Nakagawa, K. High-dose-rate interstitial brachytherapy for gynecologic malignancies–dosimetric changes during treatment period. J Radiat Res. 54(4), 663-670, 2013.

Haga, A., Sakumi, A., Okano, Y., Itoh, S., Saotome, N., Kida, S., Igaki, H., Shiraishi, K., Yamashita, H., Ohtomo, K. and Nakagawa, K. Dose verification of volumetric modulated arc therapy (VMAT) by use of in-treatment linac parameters. Radiol Phys Technol. 6(2), 335-342, 2013.

Takahashi, W., Yamashita, H., Omori, M., Kitaguchi, M., Shibata-Kobayashi, S., Sakumi, A. and Nakagawa, K. The feasibility and efficacy of stereotactic body radiotherapy for centrally-located lung tumors. Anticancer Res. 33(11), 4959-4964, 2013.

Igaki, H., Onishi, H., Nakagawa, K., Dokiya, T., Nemoto, K., Shigematsu, N., Nishimura, Y. and Hiraoka, M. A newly introduced comprehensive consultation fee in the national health insurance system in Japan: a promotive effect of multidisciplinary medical care in the field of radiation oncology–results from a questionnaire survey. Jpn J Clin Oncol. 43(12), 1233-1237, 2013.

Omori, M., Yamashita, H., Shinohara, A., Kurokawa, M., Takita, J., Hiwatari, M. and Nakagawa, K. Eleven secondary cancers after hematopoietic stem cell transplantation using a total body irradiation-based regimen in 370 consecutive pediatric and adult patients. Springerplus. 2, 424, 2013.

Matsuo, Y., Onishi, H., Nakagawa, K., Nakamura, M., Ariji, T., Kumazaki, Y., Shimbo, M., Tohyama, N., Nishio, T., Okumura, M., Shirato, H. and Hiraoka, M. Guidelines for respiratory motion management in radiation therapy. J Radiat Res. 54(3), 561-568, 2013.

英文原著

2012

Hashimoto, M., Uematsu, M., Ito, M., Hama, Y., Inomata, T., Fujii, M., Nishio, T., Nakamura, N. and Nakagawa, K. Investigation of the feasibility of a simple method for verifying the motion of a binary multileaf collimator synchronized with the rotation of the gantry for helical tomotherapy. J Appl Clin Med Phys. 13(1), 3700, 2012.

Koga, T., Maruyama, K., Tanaka, M., Ino, Y., Saito, N., Nakagawa, K., Shibahara, J. and Todo, T. Extended field stereotactic radiosurgery for recurrent glioblastoma. Cancer. 118(17), 4193-4200, 2012.

Nakamura, N., Shikama, N., Takahashi, O., Sekiguchi, K., Hama, Y., Akahane, K. and Nakagawa, K. The relationship between the bladder volume and optimal treatment planning in definitive radiotherapy for localized prostate cancer. Acta Oncol. 51(6), 730-734, 2012.

Takahashi, W., Yamashita, H., Saotome, N., Iwai, Y., Sakumi, A., Haga, A. and Nakagawa, K.　Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): Comparison of commercially available Monte Carlo dose calculation with　other algorithms. Radiat Oncol. 7(1), 20, 2012.

Yamashita, H., Nakagawa, K., Okuma, K., Sakumi, A., Haga, A., Kobayashi, R. and Ohtomo, K.　Correlation Between Bladder Volume and Irradiated Dose of Small Bowel in CT-based Planning of Intracavitary Brachytherapy for Cervical Cancer. Jpn J Clin Oncol. 42(4), 302-308, 2012. Sakumi, A., Shiraishi, K., Onoe, T., Yamamoto, K., Haga, A., Yoda, K., Ohtomo, K. and Nakagawa, K. Single-arc volumetric modulated arc therapy planning for left breast cancer and regional nodes. J Radiat Res. 53(1), 151-153, 2012.

Yamashita, H., Okuma, K., Tada, K., Shiraishi, K., Takahashi, W., Shibata-Mobayashi, S., Sakumi, A., Saotome, N., Haga, A., Onoe, T., Ino, K., Akahane, M., Ohtomo, K. and Nakagawa, K. Four-Dimensional Measurement of the Displacement of Internal Fiducial and SkinMarkers During 320-Multislice Computed Tomography Scanning of Breast Cancer. Int J Radiat Oncol Biol Phys. 84(2), 331-335, 2012.

Imae, T., Shinohara, H., Ino, K., Okano, Y., Sasaki, K., Saegusa, S., Shiraki, T., Yano, K., Kida, S., Haga, A., Nakagawa, K. and Ohtomo, K. Motion Analysis of Target duringStereotactic Radiotherapy of Lung Tumors Using Volumetric Modulated Arc Therapy. Nihon Hoshasen Gijutsu Gakkai Zasshi. 68(2), 153-161, 2012.

Kida, S., Masutani, Y., Yamashita, H., Imae, T., Matsuura, T., Saotome, N., Ohtomo, K., Nakagawa, K. and Haga, A. In-treatment 4D cone-beam CT with image-based respiratoryphase recognition. Radiol Phys Technol. 5(2), 138-147, 2012.

Isayama, H., Tsujino, T., Nakai, Y., Sasaki, T., Nakagawa, K., Yamashita, H., Aoki, T. and Koike, K. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma. World J Gastroenterol. 18(19), 2364-2370, 2012.

Murakami, N., Suzuki, S., Ito, Y., Yoshimura, R., Inaba, K., Kuroda, Y., Morota, M., Mayahara, H., Sakudo, M., Wakita, A., Okamoto, H., Sumi, M., Kagami, Y., Nakagawa, K., Ohtomo, K. and Itami, J. (106)Ruthenium Plaque Therapy (RPT) for Retinoblastoma. J. Int J Radiat Oncol Biol Phys. 84(1), 59-65, 2012. Kawashima, M., Ozawa, S., Haga, A., Sakumi, A., Kurokawa, C., Sugimoto, S., Karasawa, K., Nakagawa, K. and Sasai, K. Comparison of total MU and segment areas in VMAT and step-and-shoot IMRT plans. Radiol Phys Technol. 6(1), 14-20, 2012.

Miyamoto, Y., Nakagawa, S., Wada-Hiraike, O., Seiki, T., Tanikawa, M., Hiraike, H., Sone, K., Nagasaka, K., Oda, K., Kawana, K., Nakagawa, K., Fujii, T., Yano, T., Kozuma, S. and Taketani, Y. Sequential effects of the proteasome inhibitor bortezomib and chemotherapeutic agents in uterine cervical cancer cell lines. Oncol Rep. 29(1), 51-57, 2012.

Nakagawa, K., Kida, S., Haga, A., Masutani, Y., Yamashita, H., Onoe, T., Imae, T., Tanaka, K., Ohtomo, K. and Yoda, K. 4D digitally reconstructed radiography for verifying a lung tumor position during volumetric modulated arc therapy. J Radiat Res. 53(4), 628-632, 2012.

Nakagawa, K., Haga, A., Kida, S., Masutani, Y., Yamashita, H., Takahashi, W., Sakumi, A., Saotome, N., Shiraki, T., Ohtomo, K., Iwai, Y. and Yoda, K. 4D registration and 4D verification of lung tumor position for stereotactic volumetric modulated arc therapy using respiratory-correlated cone-beam CT. J Radiat Res. 54(1), 152-156, 2012.

Takahashi, W., Yamashita, H., Niibe, Y., Shiraishi, K., Hayakawa, K. and Nakagawa, K. Stereotactic body radiotherapy for metastatic lung cancer as oligo-recurrence: ananalysis of 42 cases. Pulm Med. 2012, 454107, 2012. doi: 10.1155/2012/454107.

英文原著

2011

Yamashita, H., Kida, S., Sakumi, A., Haga, A., Ito, S., Onoe, T., Okuma, K., Ino, K., Akahane, M., Ohtomo, K. and Nakagawa, K. Four-Dimensional Measurement of the Displacement of Internal Fiducial Markers During 320-Multislice Computed Tomography Scanning of Thoracic Esophageal Cancer. Int J Radiat Oncol Biol Phys. 79(2), 588-595, 2011.

Yamashita, H., Okuma, K., Wakui, R., Kobayashi-Shibata, S., Ohtomo, K. and Nakagawa, K. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma – A retrospective analysis. Radiother Oncol. 98(2), 255-260, 2011.

Murakami, I., Takeuchi, T., Mori-Uchino, M., Mori, S., Fujii, T., Aoki, D., Nakagawa, K. and Kanda, T. An Adeno-Associated Virus Vector Efficiently and Specifically Transduces Mouse Skeletal Muscle. Mol Biotechnol. 49(1), 1-10, 2011.

Yamashita, H., Kida, S., Sakumi, A., Haga, A., Ito, S., Onoe, T., Okuma, K., Ino, K., Akahane, M., Ohtomo, K. and Nakagawa, K. Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer. Int J Radiat Oncol Biol Phys. 79(2), 588-595, 2011.

Nakagawa, K., Kida, S., Haga, A., Masutani, Y., Yamashita, H., Imae, T., Tanaka, K., Ohtomo, K., Iwai, Y. and Yoda, K. Cone Beam Computed Tomography Data Acquisition during VMAT Delivery with Subsequent Respiratory Phase Sorting Based on Projection Image Cross-correlation. J Radiat Res. 52(1), 112-113, 2011.

Nakagawa, K., Ohkuma, K., Yamashita, H., Masuda, M., Matsumoto, Y. and Gotoh, T. Radiation therapy did not alleviate complete paralysis due to metastasis of lung adenocarcinoma to thoracic vertebrae until four months later. Acta Oncol. 50(4), 606-608, 2011.

Yoda, K. and Nakagawa, K. Extension of Van Herk’s treatment margin model for anisotropic systematic positioning errors in cartesian coordinate systema. Med Phys. 38(7), 3913-3914, 2011.

Sakumi, A., Haga, A., Kida, S., Saotome, N., Okano, Y., Shiraishi, K., Onoe, T., Yoda, K., Ohtomo, K. and Nakagawa, K. First in-situ dose calculation report using in-treatment kilovoltage cone-beam ct and in-treatment linac parameters during volumetric modulated arc therapy. J Radiat Res. 52(4), 536-537, 2011.

Okuma, K., Yamashita, H., Niibe, Y., Hayakawa, K. and Nakagawa, K. Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report. J Med Case Reports. 19(5), 111, 2011.

Kida, S., Saotome, N., Masutani, Y., Yamashita, H., Ohtomo, K., Nakagawa, K., Sakumi, A. and Haga, A. 4D-CBCT reconstruction using MV portal imaging during volumetric modulated arc therapy. Radiother Oncol. 100(3), 380-385, 2011.

Hiraike, H., Wada-Hiraike, O., Nakagawa, S., Saji, S., Maeda, D., Miyamoto, Y., Sone, K., Tanikawa, M., Oda, K., Nakagawa, K., Yano, T., Fukayama, M. and Taketani, Y. Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer. Exp Ther Med. 2(6), 1105-1109, 2011.

英文原著

2010

Miyashita, M., Yasuda, M., Baba, R., Iwase, S., Teramoto, R., Nakagawa, K., Kizawa, Y. and Shima, Y. Inter-rater reliability of proxy simple symptom assessment scale between physician and nurse: a hospital-based palliative care team setting. European Journal of Cancer Care. 19(1), 124-130, 2010.

Kan, Y., Yamashita, H., Le Pavoux, A., Ushiku, T., Ohtomo, K. and Nakagawa, K. Histological changes after single high-dose irradiation for squamous cell carcinoma arising from a burn scar. Med Oncol. 27(1), 86-90, 2010.

Nishio, T., Miyatake, A., Ogino, T., Nakagawa, K., Saijo, N. and Esumi, H. The development and clinical use of a beam ON-LINE PET system mounted on a rotating gantry port in proton therapy. Int J Radiat Oncol Biol Phys. 76(1), 277-286, 2010.

Yamashita, H., Okuma, K., Kawana, K., Nakagawa, S., Oda, K., Yano, T., Kobayashi, S., Wakui, R., Ohtomo, K. and Nakagawa, K. Comparison Between Conventional Surgery Plus Postoperative Adjuvant Radiotherapy and Concurrent Chemoradiation for FIGO Stage IIB Cervical Carcinoma: A Retrospective Study. Am J Clin Oncol. 33(6), 583-586, 2010.

Koyama, S., Wada-Hiraike, O., Nakagawa, S., Tanikawa, M., Hiraike, H., Miyamoto, Y., Sone, K., Oda, K., Fukuhara, H., Nakagawa, K., Kato, S., Yano, T. and Taketani, Y. Repression of estrogen receptor beta function by putative tumor suppressor DBC1. Biochem Biophys Res Commun. 392(3), 357-62, 2010.

Yamashita, H., Haga, A., Hayakawa, Y., Okuma, K., Yoda, K., Okano, Y., Tanaka, K., Imae, T., Ohtomo, K. and Nakagawa, K. Patient setup error and day-to-day esophageal motion error analyzed by cone-beam computed tomography in radiation therapy. Acta Oncol. 49(4), 485-90, 2010.

Miyashita, M., Yasuda, M., Baba, R., Iwase, S., Teramoto, R., Nakagawa, K., Kizawa, Y. and Shima, Y. Inter-rater reliability of proxy simple symptom assessment scale between physician and nurse: a hospital-based palliative care team setting. Eur J Cancer Care. 19(1), 124-130, 2010.

Okuma, K., Yamashita, H., Kawana, K., Nakagawa, S., Oda, K. and Nakagawa, K. Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancer. J Obstet Gynaecol Res. 36(4), 757-763, 2010.

Hachizuka, M., Yoshiuchi, K., Yamamoto, Y., Iwase, S., Nakagawa, K., Kawagoe, K. and Akabayashi, A. Development of a personal digital assistant (PDA) system to collect symptom information from home hospice patients. J Palliat Med. 13(6), 647-651, 2010.

Yamashita, H., Kobayashi-Shibata, S., Terahara, A., Okuma, K., Haga, A., Wakui, R., Ohtomo, K. and Nakagawa, K. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol. 5, 32, 2010.

Yamashita, H., Haga, A., Hayakawa, Y., Okuma, K., Yoda, K., Okano, Y., Tanaka, K., Imae, T., Ohtomo, K. and Nakagawa, K. Patient setup error and day-to-day esophageal motion error analyzed by cone-beam computed tomography in radiation therapy. Acta Oncol. 49(4), 485-490, 2010.

Nakamura, N., Shikama, N., Takahashi, O., Ito, M., Hashimoto, M., Uematsu, M., Hama, Y., Sekiguchi, K. and Nakagawa, K. Variability in bladder volumes of full bladders in definitive radiotherapy for cases of localized prostate cancer. Strahlenther Onkol. 186(11), 637-642, 2010.

英文原著

2009

Nakamura, N., Sasano, N., Yamashita, H., Igaki, H., Shiraishi, K., Terahara, A., Asakage, T., Nakao, K., Ebihara, Y., Ohtomo, K. and Nakagawa, K. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese. Auris Nasus Larynx. 36(3), 310-313, 2009.

Yamashita, H., Nakagawa, K., Hosoi, Y., Kurokawa, A., Fukuda, Y., Matsumoto, I., Misaka, T. and Abe, K. Umami taste dysfunction in patients receiving radiotherapy for head and neck cancer. Oral Oncol. 45(3), 19-23, 2009.

Igaki, H., Nakagawa, K., Yamashita, H., Terahara, A., Haga, A., Shiraishi, K., Sasano, N., Yamamoto, K., Onoe, T., Yoda, K. and Ohtomo, K. Contrast media-assisted visualization of brain metastases by kilovoltage cone-beam CT. Acta Oncol. 48(2), 314-317, 2009.

Nakagawa, K., Haga, A., Shiraishi, K., Yamashita, H., Igaki, H., Terahara, A., Ohtomo, K., Saegusa, S., Shiraki, T., Oritate, T. and Yoda, K. First clinical cone-beam CT imaging during volumetric modulated arc therapy. Radiother Oncol. 90(3), 422-423, 2009.

Yamashita, H., Murakami, N., Asari, T., Okuma, K., Ohtomo, K. and Nakagawa, K. Correlation Among Six Biologic Factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and Clinical Outcomes After Curative Chemoradiation Therapy in Squamous Cell Cervical Cancer. Int J Radiat Oncol Biol Phys. 74(4), 1165-1172, 2009.

Yamashita, H., Nakagawa, K., Asari, T., Murakami, N., Igaki, H., Okuma, K. and Ohtomo, K. Concurrent chemoradiation alone with curative intent for limited-disease small-cell esophageal cancer in nine Japanese patients. Dis Esophagus. 22(2), 113-118, 2009.

Hashimoto, M., Tomita, T., Sawada, K., Fujibuchi, T., Nishio, T. and Nakagawa, K. Dose profile measurement using an imaging plate: Evaluation of filters using Monte Carlo simulation of 4 MV x-rays. Review of Scientific Instruments. 80(4), 045101, 2009.

Yamashita, H., Okuma, K. and Nakagawa, K. Iatrogenic vulvar skin metastases after interstitial radiotherapy for recurrent cervical cancer. J Dermatol. 36(12), 663-665, 2009.

Mori-Uchino, M., Takeuchi, T., Murakami, I., Yano, T., Yasugi, T., Taketani, Y., Nakagawa, K. and Kanda, T. Enhanced transgene expression in the mouse skeletal muscle infected by the adeno-associated viral vector with the human elongation factor 1alpha promoter and a human chromatin insulator. J Gene Med. 11(7), 598-604, 2009.

Nakagawa, K., Shiraishi, K., Kida, S., Haga, A., Yamamoto, K., Saegusa, S., Terahara, A., Itoh, S., Ohtomo, K. and Yoda, K. First report on prostate displacements immediately before and after treatment relative to the position during VMAT delivery. Acta Oncol. 48(8), 1206-1208, 2009.

Haga, A., Nakagawa, K., Shiraishi, K., Itoh, S., Terahara, A., Yamashita, H., Ohtomo, K., Saegusa, S., Imae, T., Yoda, K. and Pellegrini, R. Quality assurance of volumetric modulated arc therapy using Elekta Synergy. Acta Oncol. 48(8), 1193-1197, 2009.

Igaki, H., Maruyama, K., Koga, T., Murakami, N., Tago, M., Terahara, A., Shin, M., Nakagawa, K. and Ohtomo, K. Stereotactic radiosurgery for skull base meningioma. Neurol Med Chir. 49(10), 456-61, 2009.

Yamashita, H., Okuma, K., Seto, Y., Mori, K., Kobayashi, S., Wakui, R., Ohtomo, K. and Nakagawa, K. A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma. J Surg Oncol. 100(6), 435-441, 2009.

Yamashita H, Okuma K. and Nakagawa K. Iatrogenic vulvar skin metastases after interstitial radiotherapy for recurrent cervical cancer. J Dermatol. 36(12), 663-665, 2009.

英文原著

2008

Shiraishi, K., Ishiwata, Y., Nakagawa, K., Yokochi, S., Taruki, C., Akuta, T., Ohtomo, K., Matsushima, K., Tamatani, T. and Kanegasaki, S. Enhancement of Antitumor Radiation Efficacy and Consistent Induction of the Abscopal Effect in Mice by ECI301, an Active Variant of Macrophage Inflammatory Protein-1{alpha}. Clin Cancer Res. 14(4), 1159-1166, 2008.

Murakami, N., Nakagawa, K., Yamashita, H. and Nagawa, H. Palliative radiation therapy for advanced gastrointestinal cancer. Digestion. 77(S.1), 29-35, 2008.

Takeuchi, T., Wang, L., Mori, S., Nakagawa, K., Yoshikura, H. and Kanda, T. Characterization of mouse 3t3-swiss albino cells available in Japan: necessity of quality control when used as feeders. Jpn J Infect Dis. 61(1), 9-12, 2008.

Nakagawa, K., Yamashita, H., Nakamura, N., Igaki, H., Tago, M., Hosoi, Y., Momose, T., Ohtomo, K., Muto, T. and Nagawa, H. Preoperative Radiation Response Evaluated by 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival in Locally Advanced Rectal Cancer. Dis Colon Rectum. 51(7), 1055-1060, 2008.

Yamashita, H., Nakagawa, K., Asari, T., Murakami, N., Igaki, H. and Ohtomo, K. Radiotherapy for 41 patients with stages I and II MALT lymphoma: A retrospective study. Radiother Oncol. 87(3), 412-417, 2008.

Igaki, H., Maruyama, K., Tago, M., Shin, M., Murakami, N., Koga, T., Nakagawa, K., Kawahara, N. and Ohtomo, K. Cyst Formation after Stereotactic Radiosurgery for Intracranial Meningioma. Stereotact Funct Neurosurg. 86(4), 231-236, 2008.

Igaki, H., Nakagawa, K., Shiraishi, K., Shiina, S., Kokudo, N., Terahara, A., Yamashita, H., Sasano, N., Omata, M. and Ohtomo, K. Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion. Jpn J Clin Oncol. 38(6), 438-444, 2008.

Sone, K., Nakagawa, S., Nakagawa, K., Takizawa, S., Matsumoto, Y., Nagasaka, K., Tsuruga, T., Hiraike, H., Hiraike-Wada, O., Miyamoto, Y., Oda, K., Yasugi, T., Kugu, K., Yano, T. and Taketani, Y. hScrib, a human homologue of Drosophila neoplastic tumor suppressor, is a novel death substrate targeted by caspase during the process of apoptosis. Genes Cells. 13(7), 771-785, 2008.

Yamashita H., Kadono T., Tamaki K. and Nakagawa K. Interesting response to concurrent chemoradiation in metastatic eccrine porocarcinoma. Journal of Dermatology. 35(6), 606-607, 2008.

Yoda, K., Nakagawa, K., Shiraishi, K., Okano, Y., Ohtomo, K. and Pellegrini, R.G. Dose verification of intensity modulated arc therapy using Ergo++ treatment planning system and Elekta internal multi-leaf collimators for prostate treatment. The British Journal of Radiology. 82(976), 328-331, 2008.

Nakagawa, K., Kanda, Y., Yamashita, H., Nakagawa, S., Sasano, N., Ohtomo, K., Oshima, K., Kumano, K., Ban, N., Nannya, Y., Kurokawa, M. and Chiba, S. Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI. Bone Marrow Transplantation. 42(10), 697-699, 2008.

Nakagawa, K., Yamashita, H., Igaki, H., Terahara, A., Shiraishi, K. and Yoda, K. Contrast medium-assisted stereotactic image-guided radiotherapy using kilovoltage cone-beam computed tomography. Radiat Med. 26(9), 570-572, 2008.

Murakami, N., Itami, J., Okuma, K., Marino, H., Nakagawa, K., Ban, T., Nakazato, M., Kanai, K., Naoi, K. and Fuse, M. Urethral Dose and Increment of International Prostate Symptom Score (IPSS) in Transperineal Permanent Interstitial Implant (TPI) of Prostate Cancer. Strahlenther Onkol. 184(10), 515-519, 2008.

Takemura, N., Kokudo, N., Imamura, H., Takazawa, Y., Sano, K., Sugawara, Y., Nakagawa, K., Ohtomo, K. and Makuuchi, M. Eleven-year survivor of unresectable intrahepatic cholangiocarcinoma treated using long-term UFT therapy. Hepatogastroenterology. 55(88), 1997-1999, 2008.

英文原著

2006

Nakagawa, K., Kanda, Y., Yamashita, H., Hosoi, Y., Oshima, K., Ohtomo, K., Ban N., Yamakawa, S., Nakagawa, S. and Chiba, S. Preservation of ovarian function by ovarian shielding when undergoing total body irradiation for hematopoietic stem cell transplantation. a case report of two successful cases. Bone Marrow Transplantation. 37(6), 583-587, 2006.

Yamashita, H., Nakagawa, K., Tago, M., Igaki, H., Nakamura, N., Shiraishi, K., Sasano, N. and Ohtomo, K. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study. Dis Esophagus. 19(1), 15-19, 2006.

Matsumoto, Y., Nakagawa, S., Yano, T., Takizawa, S., Nagasaka, K., Nakagawa, K., Minaguchi, T., Wada, O., Ooishi, H., Matsumoto, K., Yasugi, T., Kanda, T., Huibregtse, J. M. and Taketani, Y. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6. Journal of Medical Virology. 78(4), 501-507, 2006.

Li, Z., Hosoi, Y., Cai, K., Tanno, Y., Matsumoto, Y., Enomoto, A., Morita, A., Nakagawa, K. and Miyagawa, K. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation. Biochem and Biophys Res Commun. 341(2), 363-368, 2006.

Yamashita, H., Nakagawa, K., Tago, M., Nakamura, N., Shiraishi, K., Eda, M., Nakata, H., Nagamatsu, N., Yokoyama, R., Onimura, M. and Ohtomo, K. Taste dysfunction in patients receiving radiotherapy. Head Neck. 28(6), 508-516, 2006.

Takizawa, S., Nagasaka, K., Nakagawa, S., Yano, T., Nakagawa, K., Yasugi, T., Takeuchi, T., Kanda, T., Huibregtse, JM., Akiyama, T., Taketani, Y. Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli. Genes Cells. 11(4), 453-464, 2006.

Yamashita, H., Nakagawa, K., Tago, M., Igaki, H., Shiraishi, K., Nakamura, N., Sasano, N., Yamakawa, S. and Ohtomo, K. Small bowel perforation without tumor recurrence after radiotherapy for cervical carcinoma: report of seven cases. J Obstet Gynaecol Res. 32(2), 235-242, 2006.

Tonotsuka, N., Hosoi, Y., Miyazaki, S., Miyata, G., Sugawara, K., Mori, T., Ouchi, N., Satomi, S., Matsumoto, Y., Nakagawa, K., Miyagawa, K. and Ono, T. Heterogeneous expression of DNA-dependent protein kinase in esophageal cancer and normal epithelium. International Journal of Molecular Medicine. 18(3), 441-447, 2006.

Shiraishi, K., Nakagawa, K., Yamashita, H., Nakamura, N., Tago, M. and Ohtomo, K. Treatment planning and dosimetry of a multi-axis dynamic arc technique for prostate cancer: A comparison with IMRT. Radiat Med. 24(1), 17-22, 2006.

Yamashita, H., Nakagawa, K., Tago, M., Nakamura, N., Shiraishi, K., Mafune, K., Kaminishi, M. and Ohtomo, K. Treatment results of preoperative concurrent chemoradiotherapy followed by surgery for stage III or IV esophageal squamous cell carcinoma. Radiat Med. 24(1), 65-71, 2006.

Aoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., Kunieda, E., Inomata, T., Hayakawa, K., Katoh, N. and Kobashi, G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 295(21), 2535-2536, 2006.

Yamashita, H., Izutsu, K., Nakamura, N., Shiraishi, K., Chiba, S., Kurokawa, M., Tago, M., Igaki, H., Ohtomo, K. and Nakagawa, K. Treatment results of chemoradiation therapy for localized aggressive lymphomas: a retrospective 20-year study. Ann Hematol. 85(8), 523-529, 2006.

Yamashita, H., Nakagawa, K., Shiraishi, K., Tago, M., Igaki, H., Nakamura, N., Sasano, N., Shiina, S., Omata, M. and Ohtomo, K. External beam radiotherapy to treat intra- and extra-hepatic dissemination of hepatocellular carcinoma after radiofrequency thermal ablation. J Gastroenterol Hepatol. 21(10), 1555-1560, 2006.

Nagasaka, K., Nakagawa, S., Yano, T., Takizawa, S., Matsumoto, Y., Tsuruga, T., Nakagawa, K., Minaguchi, T., Oda, K., Hiraike-Wada, O., Ooishi, H., Yasugi, T. and Taketani, Y. Human homolog of Drosophila tumor suppressor Scribble negatively regulates cell-cycle progression from G1 to S phase by localizing at the basolateral membrane in epithelial cells. Cancer Sci. 97(11), 1217-1225, 2006.

Yamashita, H., Nakagawa, K., Nakamura, N., Abe, K., Asakage, T., Ohmoto, M., Okada, S., Matsumoto, I., Hosoi, Y., Sasano, N., Yamakawa, S. and Ohtomo, K. Relation between acute and late irradiation impairment of four basic tastes and irradiated tongue volume in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 66(5), 1422-1429, 2006.

Yamashita, H., Nakagawa, K., Tago, M., Nakamura, N., Shiraishi, K., Mafune, K., Kaminishi, M. and Ohtomo, K. The intergroup/RTOG 85-01 concurrent chemoradiation regimen for Japanese esophageal cancer. Hepatogastroenterology. 53(72), 863-868, 2006.

Nakamura, N., Igaki, H., Yamashita, H., Shiraishi, K., Tago, M., Sasano, N., Shiina, S., Omata, M., Makuuchi, M., Ohtomo, K. and Nakagawa, K. A retrospective study of radiotherapy for spinal bone metastases from hepatocellular carcinoma (HCC). Jpn J Clin Oncol. 37(1), 38-43, 2006.